Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Leukemia & Lymphoma|April 6, 2011
Stable non-transforming minimal residual disease in Philadelphia chromosome positive acute lymphoblastic leukemia after autologous transplantation: origin from neoplastic yet 'pre-leukemic' stem cells?Alexandra Böhm, Harald Herrmann, Gerlinde Mitterbauer-Hohendanner, et al.
British Journal of Haematology|July 9, 2002
Continuous complete clinical and molecular remission in two patients with refractory lymphoid malignancies after autografting followed by allogeneic stem cell transplantation with reduced intensity conditioningMargit Mitterbauer, Peter Kalhs, Felix Keil, et al.
British Journal of Haematology|December 11, 2002
Clonal T cell-mediated cyclic thrombocytopeniaWolfgang Füreder, Gerlinde Mitterbauer, Renate Thalhammer, et al.
Leukemia & Lymphoma|August 5, 2004
Molecular disease eradication is a prerequisite for long-term remission in patients with t(8;21) positive acute myeloid leukemia: a single center studyMargit Mitterbauer, Gerlinde Mitterbauer-Hohendanner, Wolfgang R Sperr, et al.
Clinical Chemistry|December 15, 2017
Digital PCR: A Sensitive and Precise Method for KIT D816V Quantification in MastocytosisGeorg Greiner, Michael Gurbisz, Franz Ratzinger, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 6, 2005
Myelomastocytic leukemia: evidence for the origin of mast cells from the leukemic clone and eradication by allogeneic stem cell transplantationWolfgang R Sperr, Johannes Drach, Alexander W Hauswirth, et al.
Cancer Genetics and Cytogenetics|February 8, 2007
A multicenter evaluation of comprehensive analysis of MLL translocations and fusion gene partners in acute leukemia using the MLL FusionChip deviceChristine J Harrison, Mike Griffiths, Fìona Moorman, et al.
Stem Cells and Development|July 26, 2013
Endogenous erythroid colony formation in chronic myeloid leukemia: a recurrent finding associated with persistent minimal residual disease under imatinibElisa Einwallner, Eva Jaeger, Gerlinde Mitterbauer-Hohendanner, et al.
Clinical Chemistry and Laboratory Medicine|February 22, 2020
Comparison of BCR-ABL1 quantification in peripheral blood and bone marrow using an International Scale-standardized assay for assessment of deep molecular response in chronic myeloid leukemiaGeorg Greiner, Franz Ratzinger, Michael Gurbisz, et al.
Haematologica|October 14, 2011
CD34(+)/CD38(-) stem cells in chronic myeloid leukemia express Siglec-3 (CD33) and are responsive to the CD33-targeting drug gemtuzumab/ozogamicinHarald Herrmann, Sabine Cerny-Reiterer, Karoline V Gleixner, et al.
Pageof 3